Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control and eventually paralysis.
Prosetin for Amyotrophic Lateral Sclerosis (ALS)
We are evaluating a new drug called Prosetin to see how safe it is and how well it is tolerated in people with ALS and healthy volunteers. This study aims to understand its effects on ALS symptoms.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitair Medisch Centrum Utrecht
Neurology & Neurosurgery
De Bilt, Netherlands
Sponsor: Projenx Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.